Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Guesses on "cash position" as at June 2022??
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(800)
•••
Comment by SouthernTierTomon Jun 11, 2022 3:02pm
234 Views
Post# 34749439

RE:RE:Guesses on "cash position" as at June 2022??

RE:RE:Guesses on "cash position" as at June 2022??Sorry I have corrected the spelling errors!

REAL people reading this ( NOT the countless ID's used buy the bullboard crew ) surely recognize "what is going on"

* MOST read bullboard or "most managed" ?? Hmmmmmm??

Thanks for all the inboxes, I wouldn't worry about it long term, it was the pump and churn in the mid 40's CAD that was most disturbing as it matched the identical bullboard program that preseeded the 30 cent financing with 35 cent warrants and 12.7M options at 25 cents cad.

I sure hope it is different this time....so do the people reading and "watching" ...hope I'm wrong!

Projections based on current burn and last reported cash position of ~2.5M at March 31/2022 indicate an amount less than 1.5M.

Given the incredible program being run here in the US...

When does the kitty need to be "topped up"?

I'm thinking $oon.

$erious replies only pls and thanks
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities